Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,486 | 693 | 99.8% |
| Education | $22.91 | 4 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,846 | 155 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,237 | 72 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,118 | 77 | $0 (2024) |
| Lilly USA, LLC | $682.49 | 47 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $669.58 | 37 | $0 (2024) |
| Amgen Inc. | $590.72 | 36 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $466.31 | 28 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $452.35 | 28 | $0 (2024) |
| ABBVIE INC. | $355.13 | 22 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $301.77 | 22 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,328 | 79 | Lilly USA, LLC ($171.83) |
| 2023 | $1,423 | 86 | Novo Nordisk Inc ($202.29) |
| 2022 | $1,243 | 78 | Novo Nordisk Inc ($234.14) |
| 2021 | $1,626 | 109 | Novo Nordisk Inc ($259.48) |
| 2020 | $1,263 | 84 | Novo Nordisk Inc ($304.88) |
| 2019 | $1,139 | 77 | Boehringer Ingelheim Pharmaceuticals, Inc. ($229.62) |
| 2018 | $1,310 | 94 | Novo Nordisk Inc ($323.08) |
| 2017 | $1,177 | 90 | Novo Nordisk Inc ($231.80) |
All Payment Transactions
697 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Cardio-renal | ||||||
| 12/10/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: VACCINE | ||||||
| 11/26/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Respiratory | ||||||
| 11/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Gastroenterology | ||||||
| 11/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: DIABETES | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: Cardio-renal | ||||||
| 11/07/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: PSYCHIATRY | ||||||
| 11/05/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: Biological | ||||||
| 10/31/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: PSYCHIATRY | ||||||
| 10/29/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $9.64 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: DIABETES | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: Respiratory | ||||||
| 09/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Cardio-renal | ||||||
| 09/24/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.85 | General |
| 09/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: DIABETES | ||||||
| 09/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Obesity | ||||||
| 09/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Respiratory | ||||||
| 09/06/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: Biological | ||||||
| 08/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Obesity | ||||||
| 08/27/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: DIABETES | ||||||
| 08/22/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $27.11 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 08/21/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 3,118 | 6,395 | $557,637 | $239,727 |
| 2022 | 32 | 2,806 | 5,595 | $500,680 | $207,969 |
| 2021 | 37 | 2,495 | 4,972 | $454,512 | $191,388 |
| 2020 | 30 | 2,381 | 4,820 | $457,110 | $178,361 |
All Medicare Procedures & Services
131 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 456 | 1,021 | $224,620 | $73,507 | 32.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 172 | 1,122 | $74,052 | $49,184 | 66.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 411 | 682 | $107,756 | $35,370 | 32.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 275 | 275 | $46,560 | $33,028 | 70.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 139 | 142 | $11,360 | $10,053 | 88.5% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 31 | 34 | $10,295 | $6,311 | 61.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 401 | 668 | $8,016 | $5,528 | 69.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 275 | 275 | $13,750 | $4,550 | 33.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 142 | 145 | $5,770 | $4,186 | 72.6% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 17 | 17 | $3,540 | $2,526 | 71.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $8,064 | $2,307 | 28.6% |
| G0181 | Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 2023 | 22 | 27 | $4,752 | $1,871 | 39.4% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 30 | 97 | $3,880 | $1,611 | 41.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 29 | 29 | $6,380 | $1,469 | 23.0% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 36 | 40 | $2,600 | $1,350 | 51.9% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 37 | 40 | $1,960 | $1,345 | 68.6% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 34 | 70 | $2,100 | $1,071 | 51.0% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 19 | 64 | $2,240 | $790.40 | 35.3% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 18 | 19 | $995.00 | $689.35 | 69.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 11 | 14 | $2,030 | $575.63 | 28.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 41 | 43 | $2,365 | $373.45 | 15.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 22 | 53 | $1,855 | $346.96 | 18.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 109 | 152 | $1,520 | $321.62 | 21.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 80 | 360 | $4,320 | $235.80 | 5.5% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 11 | 11 | $726.00 | $218.46 | 30.1% |
About Dr. Emory Walker, M.D
Dr. Emory Walker, M.D is a Family Medicine healthcare provider based in Hartwell, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1538182431.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Emory Walker, M.D has received a total of $10,509 in payments from pharmaceutical and medical device companies, with $1,328 received in 2024. These payments were reported across 697 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($10,486).
As a Medicare-enrolled provider, Walker has provided services to 10,800 Medicare beneficiaries, totaling 21,782 services with total Medicare billing of $817,445. Data is available for 4 years (2020–2023), covering 131 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Hartwell, GA
- Active Since 07/25/2006
- Last Updated 11/01/2011
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1538182431
Products in Payments
- Ozempic (Drug) $901.78
- FARXIGA (Drug) $832.25
- TRADJENTA (Drug) $684.48
- JARDIANCE (Drug) $532.85
- Kerendia (Drug) $466.31
- Victoza (Drug) $319.34
- TRULICITY (Drug) $296.37
- SOLIQUA 100/33 (Biological) $291.69
- TRINTELLIX (Drug) $283.29
- NURTEC ODT (Drug) $241.11
- Aimovig (Biological) $238.25
- TRELEGY ELLIPTA (Drug) $229.44
- Otezla (Drug) $211.93
- UBRELVY (Drug) $202.62
- INVOKANA (Drug) $195.60
- Wegovy (Drug) $191.70
- MOUNJARO (Drug) $186.09
- REXULTI (Drug) $179.97
- XIFAXAN (Drug) $172.31
- Rybelsus (Drug) $170.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Hartwell
Jodon Garringer, M.d, M.D
Family Medicine — Payments: $8,587
Dr. Bradley White, D.o, D.O
Family Medicine — Payments: $8,338
Dr. Edward Wysong, M.d, M.D
Family Medicine — Payments: $4,318
Lisa Seawright, Do, DO
Family Medicine — Payments: $3,315
Anthony Lau, Md, MD
Family Medicine — Payments: $2,936
Jenean White, Md, MD
Family Medicine — Payments: $2,616